It has been a brutal year for growth investing and I think the market is starting to realise how much growth/bio tech stocks have been beaten down on the NASDAQ...
in the past couple of days most of them have been strongly bouncing off the year lows... NVTA, TDOC, FATE... etc all up together with RCEL even though the index overall has not increased much
But that doesn’t mean stocks can’t get cheaper or volatility is going to disappear... in absence of material announcements from AVH we will continue to be at mercy of the markets - hopefully Q2 results could inject some optimism into AVH share price, otherwise it will continue to jump up and down until the clinical data released later in the year.
It has been a brutal year for growth investing and I think the...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.01 |
Change
-0.010(0.33%) |
Mkt cap ! $209.3M | |||
| Open | High | Low | Value | Volume |
| $3.03 | $3.03 | $2.97 | $144.1K | 48.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1409 | $2.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.00 | 10000 | 1 |
View Market Depth
| Last trade - 15.56pm 10/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |